PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Molecular and Clinical Pharmacology, Institute of Translational Medicine, University of Liverpool, Liverpool, UK. fmarra@liverpool.ac.uk.\', \'Department of Pharmacy, NHS Greater Glasgow and Clyde, Glasgow, UK. fmarra@liverpool.ac.uk.\', \'Department of Pharmacy, Radboud Institute for Health Sciences, Radboud University Medical Centre, Nijmegen, The Netherlands.\', \'Department of Pharmacy, Isala Hospital, Zwolle, The Netherlands.\', \'Liver Unit, Queen Elizabeth Hospital Birmingham, Birmingham, UK.\', \'Department of Molecular and Clinical Pharmacology, Institute of Translational Medicine, University of Liverpool, Liverpool, UK.\', \'Department of Pharmacy, NHS Greater Glasgow and Clyde, Glasgow, UK.\', \'Department of Pharmacy, NHS Lothian, Edinburgh, UK.\', \'Division of Infectious Diseases and Hospital Epidemiology, Departments of Medicine and Clinical Research, University Hospital of Basel, Basel, Switzerland.\', \'University of Basel, Basel, Switzerland.\', \'Royal Liverpool University Hospital, Liverpool, UK.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1007/s40268-020-00333-0
?:hasPublicationType
?:journal
  • Drugs in R&D
is ?:pmid of
?:pmid
?:pmid
  • 33336316
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • Recommendations for Dosing of Repurposed COVID-19 Medications in Patients with Renal and Hepatic Impairment.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all